In addition to clonal evolution and stem cell capacity to shape shift and evade cell death with TMZ, another response from GBM cells upon TMZ administration is over expression of the DNA repair protein O-6-methylguanine-DNA methyltransferase (MGMT), which confers resistance and shorter survival (Perry et al., 2017). The gene discussed is MGMT; the disease is glioblastoma.